Competitive Intelligence Policies, Ethics and Data Collection: Navigating the Gray Zone : Market Research Report

Competitive Intelligence Policies, Ethics and Data Collection: Navigating the Gray Zone

Published by: Best Practices, LLC

Published: Nov. 1, 2008 - 55 Pages

EXECUTIVE SUMMARY

Introduction

Research Approach

Participant Demographics

Figure 1.1 - Participating Companies

Figure 1.2 - Participant Job Titles

Figure 1.3 - Scope of Benchmark Companies

Definitions and Abbreviations

Report Structure and Organization

Key Findings

ESSENTIAL DATA SOURCES

Figure 2.1 - Multiple Data Sources are Vital

Figure 2.2 - Key Secondary Information Sources

Preferred Secondary Data Sources

Figure 2.3 - Most Effective Sources for Small Pharma

Figure 2.4 - Most Effective Large Pharma Sources

Preferred Primary Data Sources

DATA COLLECTION PROCESSES AND PRACTICES

Figure 3.1 - Key CI Employee Skills

Innovative Secondary Research

Innovative Primary Research

Figure 3.2 - Internal Information Resources

Use of Third-Party Research Vendors in Primary Research

Figure 3.3 - CI Vendor Involvement

Figure 3.4 - Primary Data Sources, Large Pharma

Figure 3.5 - Primary Data Sources, Small Pharma

Figure 3.6 - Holding Vendors to Strict Standards

Collecting Data within Set Guidelines

Figure 3.7 - Eliciting Dos and Don’ts

DEVELOPMENT AND EXAMPLES OF CI GUIDELINES

Figure 4.1 - Examples of Guidelines Content

Figure 4.2 - Guidelines, Small Pharma

Figure 4.3 - CI Guidelines, Large Pharma

Figure 4.4 - Legal creates Guidelines for Small Pharma

Figure 4.5 - Legal and CI in Large Pharma

Figure 4.6 - Process for Working Collaboratively with Legal

Figure 4.7 - Limited Support for Risky CI Practices

MANAGING EXPECTATIONS

Figure 5.1 - Manage Expectations Up Front

Figure 5.2 - CI Plays Pivotal Role in Rapid Response Situations

Figure 5.3 - Early Warning Process

BEST PRACTICES AND ADVICE FOR BUILDING A SUCCESSFUL CI FUNCTION

Figure 6.1 - Leaders Avoid Paying Honoraria for Intelligence

Advice from the Field

Figure 6.2 - Developing an Intelligence Function Takes Time

Figure 6.3 - Guidelines & Legal Relationship Reduce Squeeze on CI

Figure 6.4 - Balance Risks of Doing CI Against Risks of Not Doing It

APPENDIX A - SCIP CODE OF ETHICS AND MISSION/SCIP VISION AND MISSION STATEMENTS

SCIP Code of Ethics for CI Professionals

APPENDIX B - ECONOMIC ESPIONAGE ACT OF 1996

Abstract

In today’s fast-changing, high-pressure marketplace, the Competitive Intelligence (CI) function helps companies anticipate external threats and opportunities in a timely manner so companies can respond strategically. World-class companies maximize CI success by providing sufficient human and information resources, encouraging innovation and creativity in data collection processes, and, perhaps most importantly, adopting a clear set of operating guidelines and policies.

Guidelines that establish ethical and legal boundaries, spell out standard operating procedures and detail codes of conduct for CI practitioners increasingly are necessary to protect companies from financial and corporate risk.

CI guidelines also help practitioners to manage end-user expectations regarding what kind of information can be collected. However, rigorous guidelines and policies intended to mitigate risk sometimes can be too restrictive, preventing or hindering practitioners from doing their jobs. Effective organizations operate under balanced guidelines that are neither too limiting nor too loose.

INDUSTRIES PROFILED:

Biotech; Pharmaceutical; Health Care; Diagnostic

COMPANIES PROFILED:

Alcon Labs; Biogen Idec; Centocor; ConjuChem Biotechnologies; EMD Serono; Ethicon; Human Genome Sciences; Indegene Lifesystems; King Pharmaceuticals; PDL BioPharma; Shire Pharmaceuticals; Stiefel Laboratories; Theratechnologies; Vertex; Amgen; Baxter Healthcare; Eli Lilly & Co.; Merck & Co.; Roche Labs; Sanofi-Aventis; Takeda; Wyeth; Top Five Pharma

STUDY SNAPSHOT

This benchmarking study was conducted to understand how U.S. pharmaceutical and biotechnology organizations can optimize their CI operations while working within defined guidelines. The research examined a number of areas, including CI information sources and what is being collected. In addition, the study looked at how CI groups work with legal groups to develop standard operating procedures for data collection that are in the best interests of the organization as a whole and to maximize the CI department’s ability to deliver results. Managers and executives in CI and CI-related groups can use this report to compare critical elements of their operations with those of leading firms.

“Competitive Intelligence Policies, Ethics and Data Collection: Navigating the Gray Zone” provides a comprehensive look at how pharmaceutical and biotechnology companies optimize their CI operations while working within defined guidelines and corporate policies. This report provides benchmarks, insights and best practices in key areas such as:

Processes for effective guidelines development
Extent of employee training on guidelines
Working relationships with legal departments
Pros and cons of using third-party vendors to collect intelligence
Critical sources of secondary and primary information
Data collection practices
Rapid response programs
Attitudes about information collection practices that may be in an ethical “gray area”
Best practices for managing stakeholder expectations
Executive insights for building winning CI organizations

Vice presidents, directors and managers at 24 companies participated in this benchmarking research. In addition, selected respondents from eight of the companies participated in individual interviews.

KEY FINDINGS

The following are select key findings from the report executive summary. Additional findings are available in the full document.

Multiple Sources are Vital to Effective CI

Triangulate from multiple data sources to develop the most accurate projections.
People, processes and use of third-party vendors are keys to optimizing data collection.
Hire the right people, utilize advanced internet search techniques, collect and review data over time to distill relevant, actionable information.
Talk with employees across functions inside your company to discover information gaps.

Hold Vendors to Strict Standards

Gain experience with and knowledge of third-party research vendors.
Work collaboratively with Legal to protect the company and to obtain Legal’s buy-in and support.
Involve upper management to prove the value to the company of conducting CI.

Manage Internal Expectations Up Front

CI must help educate the employees who make inappropriate or unobtainable requests for information.
Management must stand behind CI to protect the company and ensure the long-term success of the CU function.
Link CI to the financial perspective to gain clout in the company.

Get Full Details About This Report >>

US: 800.298.5699

Int'l: +1.240.747.3093

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 300,000 market research reports, company profiles and country profiles from over 700 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

2/15/2012 - 32

Competitive Intelligence Policies, Ethics and Data Collection: Navigating the Gray Zone

Table of Contents

Abstract